Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Latvia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20101
20112
20121
20151
20161
20171
20181
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
CSL Behring1
Cardurion Pharmaceuticals, Inc.1
Eli Lilly and Company1
Esperion Therapeutics, Inc.1
Genfit1
GlaxoSmithKline1
Hoffmann-La Roche1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases13
Heart Failure5
Diabetes Mellitus, Type 24
Angina Pectoris2
Heart Diseases2
Metabolic Diseases2
Peripheral Arterial Disease2
Acute Coronary Syndrome1
Anemia1
Angina, Stable1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.